The safety of tenofovir-emtricitabine for HIV pre-exposure prophylaxis (PrEP) in individuals with active hepatitis B

The safety of tenofovir-emtricitabine for HIV pre-exposure prophylaxis (PrEP) in individuals with active hepatitis B

Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. Background: Pre-exposure prophylaxis (PrEP) with daily oral emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) prevents HIV infection. The safety and feasibility of HIV PrEP in the setting of hepatitis B virus (HBV) infection w...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Marc M. Solomon, Mauro Schechter, Albert Y. Liu, Vanessa M. McManhan, Juan V. Guanira, Robert J. Hance, Suwat Chariyalertsak, Kenneth H. Mayer, Robert M. Grant, Linda Gail Bekker, Susan Buchbinder, Martin Casapia, Esper Kallas, Javier Lama, Orlando Montoya, Valdiléa Veloso
التنسيق:	دورية
منشور في:	2018
الموضوعات:	Medicine
الوصول للمادة أونلاين:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84959166158&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/56244
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
المؤسسة:	Chiang Mai University

مواد مشابهة

The safety of tenofovir-emtricitabine for HIV pre-exposure prophylaxis (PrEP) in individuals with active hepatitis B
بواسطة: Solomon M., وآخرون
منشور في: (2017)

Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men
بواسطة: Peter L. Anderson, وآخرون
منشور في: (2018)

Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men
بواسطة: Anderson P., وآخرون
منشور في: (2017)

Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
بواسطة: Marc M. Solomon, وآخرون
منشور في: (2018)

Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
بواسطة: Marc M. Solomon, وآخرون
منشور في: (2018)

Metabolic effects of preexposure prophylaxis with coformulated tenofovir disoproxil fumarate and emtricitabine
بواسطة: David V. Glidden, وآخرون
منشور في: (2018)

Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
بواسطة: Solomon M.M., وآخرون
منشور في: (2014)

Impact of Estimated Pre-Exposure Prophylaxis (PrEP) Adherence Patterns on Bone Mineral Density in a Large PrEP Demonstration Project
بواسطة: Matthew A. Spinelli, وآخرون
منشور في: (2019)

Patterns and correlates of PrEP drug detection among MSM and transgender women in the global iPrEx study
بواسطة: Albert Liu, وآخرون
منشور في: (2018)

Patterns and correlates of PrEP drug detection among MSM and transgender women in the global iPrEx study
بواسطة: Albert Liu, وآخرون
منشور في: (2018)

International sexual partnerships may be shaped by sexual histories and socioeconomic status
بواسطة: Hong Ha M. Truong, وآخرون
منشور في: (2018)

International sexual partnerships may be shaped by sexual histories and socioeconomic status
بواسطة: Hong Ha M. Truong, وآخرون
منشور في: (2018)

Syphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trial
بواسطة: Marc M. Solomon, وآخرون
منشور في: (2018)

Syphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trial
بواسطة: Marc M. Solomon, وآخرون
منشور في: (2018)

Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial
بواسطة: Kathleen Mulligan, وآخرون
منشور في: (2018)

Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial
بواسطة: Kathleen Mulligan, وآخرون
منشور في: (2018)

International sexual partnerships may be shaped by sexual histories and socioeconomic status
بواسطة: Truong H., وآخرون
منشور في: (2017)

Brief Report: Routine Use of Oral PrEP in a Phase 2 Rectal Microbicide Study of Tenofovir Reduced-Glycerin 1% Gel (MTN-017)
بواسطة: Albert Y. Liu, وآخرون
منشور في: (2019)

Brief Report: Recovery of Bone Mineral Density after Discontinuation of Tenofovir-Based HIV Pre-exposure Prophylaxis
بواسطة: David V. Glidden, وآخرون
منشور في: (2018)

Brief Report: Recovery of Bone Mineral Density after Discontinuation of Tenofovir-Based HIV Pre-exposure Prophylaxis
بواسطة: David V. Glidden, وآخرون
منشور في: (2018)

Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men
بواسطة: Alex Carballo-Diéguez, وآخرون
منشور في: (2018)

Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men
بواسطة: Alex Carballo-Diéguez, وآخرون
منشور في: (2018)

Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial
بواسطة: Avihingsanon A.
منشور في: (2023)

Strong correlation between concentrations of tenofovir (TFV) emtricitabine (FTC) in hair and TFV diphosphate and FTC triphosphate in dried blood spots in the iPrEx open label extension: Implications for pre-exposure prophylaxis adherence monitoring
بواسطة: Monica Gandhi, وآخرون
منشور في: (2018)

Strong correlation between concentrations of tenofovir (TFV) emtricitabine (FTC) in hair and TFV diphosphate and FTC triphosphate in dried blood spots in the iPrEx open label extension: Implications for pre-exposure prophylaxis adherence monitoring
بواسطة: Monica Gandhi, وآخرون
منشور في: (2018)

HIV pre-exposure prophylaxis in transgender women: A subgroup analysis of the iPrEx trial
بواسطة: Madeline B. Deutsch, وآخرون
منشور في: (2018)

HIV pre-exposure prophylaxis in transgender women: A subgroup analysis of the iPrEx trial
بواسطة: Madeline B. Deutsch, وآخرون
منشور في: (2018)

Double oral administration of emtricitabine/tenofovir prior to virus exposure protects against highly pathogenic simian/human immunodeficiency virus infection in macaques
بواسطة: Nakasone, T., وآخرون
منشور في: (2016)

Brief Report: Validation of a Urine Tenofovir Immunoassay for Adherence Monitoring to PrEP and ART and Establishing the Cutoff for a Point-of-Care Test
بواسطة: Monica Gandhi, وآخرون
منشور في: (2019)

A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: The TARGET study
بواسطة: Cressey T., وآخرون
منشور في: (2017)

A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: The TARGET study
بواسطة: Tim R. Cressey, وآخرون
منشور في: (2018)

A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: The TARGET study
بواسطة: Tim R. Cressey, وآخرون
منشور في: (2018)

Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): A phase 3 randomised double-blind active-controlled trial
بواسطة: Molina J., وآخرون
منشور في: (2017)

Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials
بواسطة: Yeon Sook Kim, وآخرون
منشور في: (2020)

Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): A phase 3 randomised double-blind active-controlled trial
بواسطة: Jean Michel Molina, وآخرون
منشور في: (2018)

Vitamin D and Calcium Supplement Attenuate Bone Loss among HIVInfected Patients Receiving Tenofovir Disoproxil Fumarate/Emtricitabine/ Efavirenz: An Open-Label, Randomized Controlled Trial
بواسطة: Patawee Boontanondha, وآخرون
منشور في: (2020)

Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials
بواسطة: Yeon Sook Kim, وآخرون
منشور في: (2020)

Slow Uptake of PrEP: Behavioral Predictors and the Influence of Price on PrEP Uptake Among MSM with a High Interest in PrEP
بواسطة: Mart van Dijk, وآخرون
منشور في: (2022)

Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide in adolescents and children with HIV: week 48 results of a single-arm, open-label, multicentre, phase 2/3 trial
بواسطة: Aditya H. Gaur, وآخرون
منشور في: (2022)

Efficacy and safety of switching to bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed Asian adults living with HIV: A pooled analysis from three international phase III randomized trials
بواسطة: Avihingsanon A.
منشور في: (2023)